NCT06119100

Brief Summary

The continuous increase in the incidence of end stage renal disease and hemodialysis patients, has raised the interest of the vascular access scientific community and many researchers are currently investigating the potential mechanisms of arteriovenous fistulas (AVF) dysfunction. Roy-Chaudhury et al. were the first to suggest neointimal hyperplasia (NIH) as the main reason of AVF dysfunction and vessel negative remodeling as another important factor. First, Yamamoto et al. described 3 stenotic lesions categories of arteriovenous grafts (AVG) observed by ultrasonography: 1. vascular constriction type, 2. neointimal hyperplasia type, 3. mixed type (constriction and neointimal hyperplastic type). The main goals of this prospective observetional study are:

  • The characterization of AVF stenotic lesions by ultrasonography
  • The correlation of the stenotic lesion type with the outcomes of percutaneous transluminal angioplasty and the rate of reintervention.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2020

Completed
3.2 years until next milestone

First Submitted

Initial submission to the registry

October 31, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 7, 2023

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

November 7, 2023

Status Verified

November 1, 2023

Enrollment Period

4.2 years

First QC Date

October 31, 2023

Last Update Submit

November 3, 2023

Conditions

Keywords

angioplastyautologous artriovenous fistuladialysisultrasoundstenosisstenosis type characterization

Outcome Measures

Primary Outcomes (2)

  • Correlation of target lesion reintervention (TLR) due to clinical recurrence and lesion type

    The correlation of the speciific lesion type classified based on the pre-procedural ultrasonographic assessment and the target lesion reintervention rate due to clinical recurrence, will be investigated

    6 months

  • Lesion characterization

    Lesion type will be classified as restrictive, hyperplastic or mixed based on the pre-procedural Duplex ultrasound assessment and the rates of each type will be recorded.

    Less than 48 hours before the procedure

Secondary Outcomes (4)

  • Restenosis characterization post angioplasty

    6 months

  • AVF survival

    6 months

  • Binary restenosis rate

    6 months

  • Periprocedural complication rate

    Up to 48 hours post-procedure

Interventions

Target lesion type will be classified as restrictive, hyperplastic or mixed using high frequency Duplex ultrasound, before the angioplasty procedure and at 6 months follow up.

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patiens between 18and 90 years of age, reffered due to failing AVF and scheduled to undergo fluoroscopically-guided, high-pressure balloon angioplasty of a significant stenosis within the dialysis access circuite.

You may qualify if:

  • Patiens with failing AVF scheduled to undergo fluoroscopically-guided high-pressure balloon angioplasty
  • Signed study concent form

You may not qualify if:

  • Patients undergoing dialysis via arteriovenous graft (AVG)
  • Contraindications to angioplasty
  • Immature AVF

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

"Attikon" University General Hospital

Athens, Attica, 12461, Greece

RECRUITING

MeSH Terms

Conditions

Constriction, Pathologic

Condition Hierarchy (Ancestors)

Pathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Diagnostic and Interventional Radiology

Study Record Dates

First Submitted

October 31, 2023

First Posted

November 7, 2023

Study Start

September 1, 2020

Primary Completion

November 1, 2024

Study Completion

December 1, 2024

Last Updated

November 7, 2023

Record last verified: 2023-11

Locations